Ledger.Open graph →
SEC Form D · filed September 1, 2017

SpringWorks Therapeutics, LLC

Offering
$103.0M
Sold
$12.8M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
BALTIMORE, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Carl L. Gordon · New York, NYDirectorPeter Keen · Cambridge, United KingdomDirectorStephen Squinto · Woodbridge, CTDirectorPeter Keen · Cambridge, United KingdomDirectorDaniel Lynch · Waltham, MAExec · DirectorFreda Lewis-Hall, M.D · New York, NYDirectorLara Sullivan, M.D · Baltimore, MDExec · DirectorJeff Schwartz · Louisville, KYDirectorStephen Squinto · HANOVER, NHDirectorDeval Patrick · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗